| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,099 |
2,894 |
$291K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,496 |
2,429 |
$133K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,954 |
2,471 |
$97K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
657 |
656 |
$55K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
575 |
575 |
$48K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
680 |
670 |
$35K |
| 90461 |
|
806 |
805 |
$31K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
385 |
384 |
$30K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
2,936 |
2,932 |
$27K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
273 |
273 |
$25K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
323 |
323 |
$23K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,654 |
1,605 |
$20K |
| 99050 |
|
1,016 |
997 |
$17K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
505 |
495 |
$14K |
| 96127 |
|
1,346 |
1,343 |
$14K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
380 |
378 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,390 |
1,383 |
$10K |
| 36416 |
|
713 |
703 |
$7K |
| 99177 |
|
282 |
282 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
201 |
201 |
$4K |
| 83655 |
|
186 |
186 |
$2K |
| 80061 |
Lipid panel |
146 |
141 |
$2K |
| 81003 |
|
577 |
566 |
$1K |
| 94760 |
|
449 |
446 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
78 |
77 |
$921.18 |
| 87081 |
|
62 |
61 |
$424.08 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
16 |
16 |
$377.92 |
| 99188 |
|
13 |
13 |
$338.00 |
| 87807 |
|
26 |
26 |
$307.06 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
16 |
14 |
$244.16 |
| 36415 |
Collection of venous blood by venipuncture |
67 |
64 |
$149.59 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
13 |
12 |
$3.90 |